首页 > 最新文献

Medical sciences (Basel, Switzerland)最新文献

英文 中文
Safety and Efficacy of Corneal Cross-Linking in Patients Affected by Keratoconus: Long-Term Results. 角膜交联治疗圆锥角膜患者的安全性和有效性:长期结果。
Q1 Medicine Pub Date : 2023-06-16 DOI: 10.3390/medsci11020043
Karl Anders Knutsson, Paola Noemi Genovese, Giorgio Paganoni, Oriella Ambrosio, Giulio Ferrari, Arianna Zennato, Michela Caccia, Madeleine Cataldo, Paolo Rama

The present study evaluated the effectiveness and safety of corneal collagen cross-linking (CXL). A total of 886 eyes with progressive keratoconus were enrolled in a retrospective cohort study in a tertiary care university hospital. CXL was performed using a standard epithelium-off Dresden protocol. Visual outcomes, maximum keratometry (Kmax), demarcation line measurements, and complications were recorded. Visual outcomes and keratometric data were analyzed in a subgroup comprising 610 eyes. Uncorrected distance visual acuity (UDVA) improved from 0.49 ± 0.38 LogMAR to 0.47 ± 0.39 LogMAR (p = 0.03, n = 610) three years after the procedure, while corrected distance visual acuity (CDVA) improved from 0.15 ± 0.14 LogMAR to 0.14 ± 0.15 LogMAR (p = 0.007, n = 610). A significant reduction of Kmax from 56.28 ± 6.10 to 54.98 ± 6.19 (p < 0.001, n = 610) was observed three years after CXL. In five eyes (0.82%, 5/610) keratoconus progression continued after CXL. Three eyes were retreated successfully with documented refractive and topographic stability after five years. In the 35 eyes that completed 10 years of follow-up, mean visual acuity and topographic parameters remained stable. In conclusion, CXL is a safe and effective treatment for avoiding keratoconus progression. Long-term data are encouraging, supporting a high safety profile for this procedure.

本研究评价了角膜胶原交联(CXL)的有效性和安全性。在一所三级保健大学医院进行了一项回顾性队列研究,共纳入了886只进行性圆锥角膜。CXL采用标准的上皮脱落德累斯顿方案进行。记录视力、最大角膜曲率(Kmax)、分界线测量值和并发症。在一个由610只眼睛组成的亚组中分析视力结果和角膜测量数据。术后3年未矫正距离视力(UDVA)由0.49±0.38 LogMAR改善至0.47±0.39 LogMAR (p = 0.03, n = 610),矫正距离视力(CDVA)由0.15±0.14 LogMAR改善至0.14±0.15 LogMAR (p = 0.007, n = 610)。术后3年Kmax由56.28±6.10降至54.98±6.19 (p < 0.001, n = 610)。5只眼(0.82%,5/610)在CXL后圆锥角膜继续恶化。3只眼术后5年屈光稳定性和地形稳定性均有记录。在完成10年随访的35只眼中,平均视力和地形参数保持稳定。综上所述,CXL是一种安全有效的避免圆锥角膜进展的治疗方法。长期数据令人鼓舞,支持该手术的高安全性。
{"title":"Safety and Efficacy of Corneal Cross-Linking in Patients Affected by Keratoconus: Long-Term Results.","authors":"Karl Anders Knutsson,&nbsp;Paola Noemi Genovese,&nbsp;Giorgio Paganoni,&nbsp;Oriella Ambrosio,&nbsp;Giulio Ferrari,&nbsp;Arianna Zennato,&nbsp;Michela Caccia,&nbsp;Madeleine Cataldo,&nbsp;Paolo Rama","doi":"10.3390/medsci11020043","DOIUrl":"https://doi.org/10.3390/medsci11020043","url":null,"abstract":"<p><p>The present study evaluated the effectiveness and safety of corneal collagen cross-linking (CXL). A total of 886 eyes with progressive keratoconus were enrolled in a retrospective cohort study in a tertiary care university hospital. CXL was performed using a standard epithelium-off Dresden protocol. Visual outcomes, maximum keratometry (Kmax), demarcation line measurements, and complications were recorded. Visual outcomes and keratometric data were analyzed in a subgroup comprising 610 eyes. Uncorrected distance visual acuity (UDVA) improved from 0.49 ± 0.38 LogMAR to 0.47 ± 0.39 LogMAR (<i>p</i> = 0.03, n = 610) three years after the procedure, while corrected distance visual acuity (CDVA) improved from 0.15 ± 0.14 LogMAR to 0.14 ± 0.15 LogMAR (<i>p</i> = 0.007, n = 610). A significant reduction of Kmax from 56.28 ± 6.10 to 54.98 ± 6.19 (<i>p</i> < 0.001, n = 610) was observed three years after CXL. In five eyes (0.82%, 5/610) keratoconus progression continued after CXL. Three eyes were retreated successfully with documented refractive and topographic stability after five years. In the 35 eyes that completed 10 years of follow-up, mean visual acuity and topographic parameters remained stable. In conclusion, CXL is a safe and effective treatment for avoiding keratoconus progression. Long-term data are encouraging, supporting a high safety profile for this procedure.</p>","PeriodicalId":74152,"journal":{"name":"Medical sciences (Basel, Switzerland)","volume":"11 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302271/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10096470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiology, Risk Factors, and Prevention of Head and Neck Squamous Cell Carcinoma. 头颈部鳞状细胞癌的流行病学、风险因素和预防。
Q1 Medicine Pub Date : 2023-06-13 DOI: 10.3390/medsci11020042
Adam Barsouk, John Sukumar Aluru, Prashanth Rawla, Kalyan Saginala, Alexander Barsouk

Head and neck squamous cell carcinoma (HNSCC) is a group of malignancies, involving the oral cavity, pharynx, hypopharynx, larynx, nasal cavity, and salivary glands, that together compose the seventh most common cancer diagnosis worldwide. With 890,000 new cases and 450,000 deaths annually per GLOBOCAN estimates, HNSCC accounts for roughly 4.5% of cancer diagnoses and deaths. In the developing world, the incidence of HNSCC is growing with increasing consumption of tobacco (smoked or chewed), alcohol, and areca nut (betel quid). Alcohol and tobacco have a synergistic effect, with the heavy consumption of both increasing HNSCC risk 40-fold. In developed nations, HPV-related HNSCC surpasses tobacco- and alcohol-related disease. HPV-related HNSCC more commonly affects the oropharynx, hypopharynx, and larynx than the oral cavity, and is associated with a significantly longer median survival (130 months vs. 20 months). Discrepancies in etiology as well as disparities in lifestyle choices and access to healthcare may account for the greater incidence and poorer survival of HNSCC among minority and lower-socioeconomic-status communities in developed nations. Pharmacotherapy and counseling together have been shown to be effective in promoting smoking and alcohol cessation. Education on cancer risk and community engagement have reduced areca nut consumption in Asia as well as in diaspora communities. HPV vaccination, starting at age 11-12 for both sexes, has been shown to reduce the prevalence of high-risk HPV serologies and prevent pre-cancerous lesions of the cervix, vagina, and vulva. As of 2020, 58.6% of eligible adolescents in the US have received the full two-vaccine series. Increased adoption of vaccination, education on safe sex practices, and routine visual oral screening for high-risk patients would curb growing HNSCC incidence in developed nations.

头颈部鳞状细胞癌(HNSCC)是一组涉及口腔、咽、下咽、喉、鼻腔和唾液腺的恶性肿瘤,在全球癌症诊断中占第七位。据 GLOBOCAN 估计,HNSCC 每年新增病例 890,000 例,死亡 450,000 例,约占癌症诊断和死亡病例的 4.5%。在发展中国家,随着烟草(吸食或咀嚼)、酒精和槟榔(槟榔)消费量的增加,HNSCC 的发病率也在不断上升。酒精和烟草具有协同作用,大量饮用这两种饮品会使 HNSCC 风险增加 40 倍。在发达国家,HPV 相关 HNSCC 的发病率超过了烟草和酒精相关疾病。与口腔相比,HPV 相关 HNSCC 更常影响口咽、下咽和喉部,而且中位生存期明显更长(130 个月对 20 个月)。在发达国家,少数民族和社会经济地位较低的群体中 HNSCC 的发病率较高,存活率较低,这可能与病因学的差异以及生活方式选择和获得医疗保健服务方面的差异有关。事实证明,药物疗法和心理咨询相结合可有效促进戒烟戒酒。关于癌症风险的教育和社区参与减少了亚洲和散居地社区的亚斯卡坚果消费量。男女儿童从 11-12 岁开始接种人乳头瘤病毒疫苗,已证明可降低高危人群的人乳头瘤病毒血清反应率,预防宫颈、阴道和外阴癌前病变。截至 2020 年,美国有 58.6% 符合条件的青少年接种了全部两联疫苗。更多采用疫苗接种、安全性行为教育以及对高危患者进行常规口腔视觉筛查,将遏制发达国家不断增长的 HNSCC 发病率。
{"title":"Epidemiology, Risk Factors, and Prevention of Head and Neck Squamous Cell Carcinoma.","authors":"Adam Barsouk, John Sukumar Aluru, Prashanth Rawla, Kalyan Saginala, Alexander Barsouk","doi":"10.3390/medsci11020042","DOIUrl":"10.3390/medsci11020042","url":null,"abstract":"<p><p>Head and neck squamous cell carcinoma (HNSCC) is a group of malignancies, involving the oral cavity, pharynx, hypopharynx, larynx, nasal cavity, and salivary glands, that together compose the seventh most common cancer diagnosis worldwide. With 890,000 new cases and 450,000 deaths annually per GLOBOCAN estimates, HNSCC accounts for roughly 4.5% of cancer diagnoses and deaths. In the developing world, the incidence of HNSCC is growing with increasing consumption of tobacco (smoked or chewed), alcohol, and areca nut (betel quid). Alcohol and tobacco have a synergistic effect, with the heavy consumption of both increasing HNSCC risk 40-fold. In developed nations, HPV-related HNSCC surpasses tobacco- and alcohol-related disease. HPV-related HNSCC more commonly affects the oropharynx, hypopharynx, and larynx than the oral cavity, and is associated with a significantly longer median survival (130 months vs. 20 months). Discrepancies in etiology as well as disparities in lifestyle choices and access to healthcare may account for the greater incidence and poorer survival of HNSCC among minority and lower-socioeconomic-status communities in developed nations. Pharmacotherapy and counseling together have been shown to be effective in promoting smoking and alcohol cessation. Education on cancer risk and community engagement have reduced areca nut consumption in Asia as well as in diaspora communities. HPV vaccination, starting at age 11-12 for both sexes, has been shown to reduce the prevalence of high-risk HPV serologies and prevent pre-cancerous lesions of the cervix, vagina, and vulva. As of 2020, 58.6% of eligible adolescents in the US have received the full two-vaccine series. Increased adoption of vaccination, education on safe sex practices, and routine visual oral screening for high-risk patients would curb growing HNSCC incidence in developed nations.</p>","PeriodicalId":74152,"journal":{"name":"Medical sciences (Basel, Switzerland)","volume":"11 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304137/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10078206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic Value of HIF-1α-Induced Genes in Sepsis/Septic Shock. hif -1α-诱导基因在脓毒症/感染性休克中的预后价值。
Q1 Medicine Pub Date : 2023-06-12 DOI: 10.3390/medsci11020041
Nikolaos S Lotsios, Chrysi Keskinidou, Edison Jahaj, Zafeiria Mastora, Ioanna Dimopoulou, Stylianos E Orfanos, Niki Vassilaki, Alice G Vassiliou, Anastasia Kotanidou

Hypoxia is characterized as one of the main consequences of sepsis, which is recognized as the leading cause of death in intensive care unit (ICU) patients. In this study, we aimed to examine whether the expression levels of genes regulated under hypoxia could be utilized as novel biomarkers for sepsis prognosis in ICU patients. Whole blood expression levels of hypoxia-inducible factor-1α (HIF1A), interferon-stimulated gene 15 (ISG15), hexokinase 2 (HK2), lactate dehydrogenase (LDHA), heme oxygenase-1 (HMOX1), erythropoietin (EPO), and the vascular endothelial growth factor A (VEGFA) were measured on ICU admission in 46 critically ill, initially non-septic patients. The patients were subsequently divided into two groups, based on the development of sepsis and septic shock (n = 25) or lack thereof (n = 21). HMOX1 mRNA expression was increased in patients who developed sepsis/septic shock compared to the non-septic group (p < 0.0001). The ROC curve, multivariate logistic regression, and Kaplan-Meier analysis demonstrated that HMOX1 expression could be utilized for sepsis and septic shock development probability. Overall, our results indicate that HMOX1 mRNA levels have the potential to be a valuable predictive factor for the prognosis of sepsis and septic shock in ICU patients.

缺氧被认为是脓毒症的主要后果之一,脓毒症被认为是重症监护病房(ICU)患者死亡的主要原因。在这项研究中,我们旨在探讨缺氧下调节的基因表达水平是否可以作为ICU患者脓毒症预后的新生物标志物。测定46例危重患者入院时缺氧诱导因子-1α (HIF1A)、干扰素刺激基因15 (ISG15)、已糖激酶2 (HK2)、乳酸脱氢酶(LDHA)、血红素加氧酶-1 (HMOX1)、促红细胞生成素(EPO)、血管内皮生长因子A (VEGFA)的全血表达水平。随后,根据是否发生败血症和感染性休克(n = 25)或是否发生败血症和感染性休克(n = 21),将患者分为两组。与非脓毒症组相比,发生脓毒症/感染性休克的患者HMOX1 mRNA表达增加(p < 0.0001)。ROC曲线、多因素logistic回归和Kaplan-Meier分析表明,HMOX1表达可用于脓毒症和脓毒性休克发生概率。总之,我们的研究结果表明,HMOX1 mRNA水平有可能成为ICU患者脓毒症和脓毒性休克预后的一个有价值的预测因素。
{"title":"Prognostic Value of HIF-1α-Induced Genes in Sepsis/Septic Shock.","authors":"Nikolaos S Lotsios,&nbsp;Chrysi Keskinidou,&nbsp;Edison Jahaj,&nbsp;Zafeiria Mastora,&nbsp;Ioanna Dimopoulou,&nbsp;Stylianos E Orfanos,&nbsp;Niki Vassilaki,&nbsp;Alice G Vassiliou,&nbsp;Anastasia Kotanidou","doi":"10.3390/medsci11020041","DOIUrl":"https://doi.org/10.3390/medsci11020041","url":null,"abstract":"<p><p>Hypoxia is characterized as one of the main consequences of sepsis, which is recognized as the leading cause of death in intensive care unit (ICU) patients. In this study, we aimed to examine whether the expression levels of genes regulated under hypoxia could be utilized as novel biomarkers for sepsis prognosis in ICU patients. Whole blood expression levels of hypoxia-inducible factor-1α (<i>HIF1A</i>), interferon-stimulated gene 15 (<i>ISG15</i>), hexokinase 2 (<i>HK2</i>), lactate dehydrogenase (<i>LDHA</i>), heme oxygenase-1 (<i>HMOX1</i>), erythropoietin (<i>EPO</i>), and the vascular endothelial growth factor A (<i>VEGFA</i>) were measured on ICU admission in 46 critically ill, initially non-septic patients. The patients were subsequently divided into two groups, based on the development of sepsis and septic shock (n = 25) or lack thereof (n = 21). <i>HMOX1</i> mRNA expression was increased in patients who developed sepsis/septic shock compared to the non-septic group (<i>p</i> < 0.0001). The ROC curve, multivariate logistic regression, and Kaplan-Meier analysis demonstrated that <i>HMOX1</i> expression could be utilized for sepsis and septic shock development probability. Overall, our results indicate that <i>HMOX1</i> mRNA levels have the potential to be a valuable predictive factor for the prognosis of sepsis and septic shock in ICU patients.</p>","PeriodicalId":74152,"journal":{"name":"Medical sciences (Basel, Switzerland)","volume":"11 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300988/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10078207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Comprehensive Geriatric Care in Older Adults: Walking Ability after an Acute Fracture. 老年人的综合老年护理:急性骨折后的行走能力。
Q1 Medicine Pub Date : 2023-05-29 DOI: 10.3390/medsci11020040
Ulrich Niemöller, Andreas Arnold, Thomas Stein, Martin Juenemann, Damir Erkapic, Josef Rosenbauer, Karel Kostev, Marco Meyer, Christian Tanislav

Background/objectives: Comprehensive Geriatric Care (CGC) is a specific multimodal treatment for older patients. In the current study, we aimed to investigate walking performance after CGC in medically ill patients versus those with fractures.

Methods: The timed up and go test (TuG), a 5-grade scale assessment (1 = no walking impairment to 5 = no walking ability at all) for evaluating individual walking ability was performed in all patients who underwent CGC prior to and after treatment. Factors associated with improvement in walking ability were analyzed in the subgroup of patients with fractures.

Results: Out of 1263 hospitalized patients, 1099 underwent CGC (median age: 83.1 years (IQR 79.0-87.8 years); 64.1% were female). Patients with fractures (n = 300) were older than those without (n = 799), (median 85.6 versus 82.4 years, p = 0.001). Improvement in TuG after CGC was found in 54.2% of the fracture patients compared to just 45.9% of those without fractures. In fracture group patients, TuG improved from median 5 on admission to median 3 on discharge (p = 0.001). In fracture patients, improvement in walking ability was associated with higher Barthel index values on admission (median 45 (IQR: 35-55) versus 35 (IQR: 20-50): p = 0.001) and Tinetti assessment scores (median 9 (IQR: 4-14.25) versus 5 (IQR: 0-13); p = 0.001) and was negatively associated with the diagnosis of dementia (21.4% versus 31.5%; p = 0.058).

Conclusion: CGC improved walking ability in more than half of all patients examined. Older patients in particular might benefit from undergoing the procedure after an acute fracture. A better initial functional status favors a positive result following the treatment.

背景/目的:综合老年护理(Comprehensive Geriatric Care, CGC)是针对老年患者的一种特殊的多模式治疗。在目前的研究中,我们的目的是调查内科疾病患者与骨折患者在CGC后的行走表现。方法:对所有接受CGC的患者在治疗前后进行了计时行走测试(TuG),并进行了5级量表评估(1 =无行走障碍至5 =完全没有行走能力),以评估个体行走能力。在骨折患者亚组中分析与行走能力改善相关的因素。结果:1263例住院患者中,1099例接受了CGC(中位年龄:83.1岁(IQR 79.0-87.8岁);64.1%为女性)。骨折患者(n = 300)比无骨折患者(n = 799)年龄大(中位85.6岁比82.4岁,p = 0.001)。54.2%的骨折患者在CGC后的TuG有改善,而非骨折患者的这一比例仅为45.9%。骨折组患者的TuG从入院时的中位数5提高到出院时的中位数3 (p = 0.001)。在骨折患者中,行走能力的改善与入院时较高的Barthel指数(中位数45 (IQR: 35-55)对35 (IQR: 20-50): p = 0.001)和Tinetti评估评分(中位数9 (IQR: 4-14.25)对5 (IQR: 0-13)相关;P = 0.001),与痴呆的诊断呈负相关(21.4%对31.5%;P = 0.058)。结论:CGC改善了一半以上患者的行走能力。特别是老年患者在急性骨折后进行手术可能会受益。良好的初始功能状态有利于治疗后的阳性结果。
{"title":"Comprehensive Geriatric Care in Older Adults: Walking Ability after an Acute Fracture.","authors":"Ulrich Niemöller,&nbsp;Andreas Arnold,&nbsp;Thomas Stein,&nbsp;Martin Juenemann,&nbsp;Damir Erkapic,&nbsp;Josef Rosenbauer,&nbsp;Karel Kostev,&nbsp;Marco Meyer,&nbsp;Christian Tanislav","doi":"10.3390/medsci11020040","DOIUrl":"https://doi.org/10.3390/medsci11020040","url":null,"abstract":"<p><strong>Background/objectives: </strong>Comprehensive Geriatric Care (CGC) is a specific multimodal treatment for older patients. In the current study, we aimed to investigate walking performance after CGC in medically ill patients versus those with fractures.</p><p><strong>Methods: </strong>The timed up and go test (TuG), a 5-grade scale assessment (1 = no walking impairment to 5 = no walking ability at all) for evaluating individual walking ability was performed in all patients who underwent CGC prior to and after treatment. Factors associated with improvement in walking ability were analyzed in the subgroup of patients with fractures.</p><p><strong>Results: </strong>Out of 1263 hospitalized patients, 1099 underwent CGC (median age: 83.1 years (IQR 79.0-87.8 years); 64.1% were female). Patients with fractures (<i>n</i> = 300) were older than those without (<i>n</i> = 799), (median 85.6 versus 82.4 years, <i>p</i> = 0.001). Improvement in TuG after CGC was found in 54.2% of the fracture patients compared to just 45.9% of those without fractures. In fracture group patients, TuG improved from median 5 on admission to median 3 on discharge (<i>p</i> = 0.001). In fracture patients, improvement in walking ability was associated with higher Barthel index values on admission (median 45 (IQR: 35-55) versus 35 (IQR: 20-50): <i>p</i> = 0.001) and Tinetti assessment scores (median 9 (IQR: 4-14.25) versus 5 (IQR: 0-13); <i>p</i> = 0.001) and was negatively associated with the diagnosis of dementia (21.4% versus 31.5%; <i>p</i> = 0.058).</p><p><strong>Conclusion: </strong>CGC improved walking ability in more than half of all patients examined. Older patients in particular might benefit from undergoing the procedure after an acute fracture. A better initial functional status favors a positive result following the treatment.</p>","PeriodicalId":74152,"journal":{"name":"Medical sciences (Basel, Switzerland)","volume":"11 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301278/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10078201","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identifying Activities from an Intervention to Promote Sleep in Hospitalised Patients Using the Focus Mapping Technique. 使用焦点映射技术识别促进住院患者睡眠的干预活动。
Q1 Medicine Pub Date : 2023-05-26 DOI: 10.3390/medsci11020039
Manuel Armayones Ruiz, Noemí Robles, Iolanda Graupera Diez, Raimon Camps Salat, Joan Escarrabill Sanglas, Elena Salas Marco

Background: Sleep is an essential element for patients' recovery during a period of hospitalisation. Hospital Clínic de Barcelona has developed the ClíNit project to promote patients' sleep by identifying elements that affect the quality of sleep and implementing actions to improve rest at night.

Objective: Our aim is to select actions to improve sleep quality.

Methods: The study population included night-shift nurses from two clinical units where the pilot actions were to be carried out (n: 14). The nurses prioritised actions to improve sleep quality using the methodology proposed by Fogg: clarification, magic wand, crispification, and the focus-mapping technique.

Results: Two sessions were organised for each unit and 32 actions considered high impact and easy to implement were proposed, of which 43.75% (14/32) were directly dependent on nurses. It was then agreed to implement four of these pilot studies.

Conclusions: One aspect worth highlighting is that using prioritization techniques such as the Fogg technique is a good strategy to implement the general objectives of intervention programmes in large organizations in an easy way.

背景:睡眠是病人在住院期间康复的重要因素。Clínic de Barcelona医院制定了ClíNit项目,通过确定影响睡眠质量的因素和实施改善夜间休息的行动来促进患者的睡眠。目的:我们的目的是选择改善睡眠质量的行动。方法:研究人群包括来自两个临床单位的夜班护士,这些临床单位将开展试点行动(n: 14)。护士使用Fogg提出的方法:澄清、魔棒、脆化和焦点映射技术,对改善睡眠质量的行动进行优先排序。结果:每个单位组织了2次会议,提出了32项影响大、容易实施的行动,其中43.75%(14/32)的行动直接依赖于护士。然后商定执行其中四项试点研究。结论:值得强调的一个方面是,使用优先排序技术,如Fogg技术,是一种很好的策略,可以以一种简单的方式在大型组织中实现干预方案的总体目标。
{"title":"Identifying Activities from an Intervention to Promote Sleep in Hospitalised Patients Using the Focus Mapping Technique.","authors":"Manuel Armayones Ruiz,&nbsp;Noemí Robles,&nbsp;Iolanda Graupera Diez,&nbsp;Raimon Camps Salat,&nbsp;Joan Escarrabill Sanglas,&nbsp;Elena Salas Marco","doi":"10.3390/medsci11020039","DOIUrl":"https://doi.org/10.3390/medsci11020039","url":null,"abstract":"<p><strong>Background: </strong>Sleep is an essential element for patients' recovery during a period of hospitalisation. Hospital Clínic de Barcelona has developed the ClíNit project to promote patients' sleep by identifying elements that affect the quality of sleep and implementing actions to improve rest at night.</p><p><strong>Objective: </strong>Our aim is to select actions to improve sleep quality.</p><p><strong>Methods: </strong>The study population included night-shift nurses from two clinical units where the pilot actions were to be carried out (n: 14). The nurses prioritised actions to improve sleep quality using the methodology proposed by Fogg: clarification, magic wand, crispification, and the focus-mapping technique.</p><p><strong>Results: </strong>Two sessions were organised for each unit and 32 actions considered high impact and easy to implement were proposed, of which 43.75% (14/32) were directly dependent on nurses. It was then agreed to implement four of these pilot studies.</p><p><strong>Conclusions: </strong>One aspect worth highlighting is that using prioritization techniques such as the Fogg technique is a good strategy to implement the general objectives of intervention programmes in large organizations in an easy way.</p>","PeriodicalId":74152,"journal":{"name":"Medical sciences (Basel, Switzerland)","volume":"11 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302051/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10096467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medical Treatment in Heart Failure with Reduced Ejection Fraction: A Proposed Algorithm Based on the Patient's Electrolytes and Congestion Status. 射血分数降低的心力衰竭的医疗治疗:一种基于患者电解质和充血状态的拟议算法。
Q1 Medicine Pub Date : 2023-05-24 DOI: 10.3390/medsci11020038
Ioannis Paraskevaidis, Andrew Xanthopoulos, Nikolaos Karamichalakis, Filippos Triposkiadis, Elias Tsougos

In heart failure (HF) with reduced ejection fraction (HFrEF), four classes of drugs (β-blockers, angiotensin-converting enzyme inhibitors/angiotensin receptor neprilysin inhibitors, mineralocorticoid receptor antagonists, and the most recent Sodium-Glucose Co-Transporters 2 Inhibitors) have demonstrated positive results in randomized controlled trials (RCTs). Nevertheless, the latest RCTs are not proper for comparison since they were carried out at various times with dissimilar background therapies and the patients enrolled did not have the same characteristics. The difficulty of extrapolating from these trials and proposing a common framework appropriate for all cases is thus obvious. Despite the fact that these four agents are now the fundamental pillars of HFrEF treatment, the built-up algorithm of initiation and titration is a matter of debate. Electrolyte disturbances are common in HFrEF patients and can be attributed to several factors, such as the use of diuretics, renal impairment, and neurohormonal activation. We have identified several HFrEF phenotypes according to their sodium (Na+) and potassium (K+) status in a "real world" setting and suggest an algorithm on how to introduce the most appropriate drug and set up therapy based on the patients' electrolytes and the existence of congestion.

在射血分数降低的心力衰竭(HF)中,四类药物(β-阻滞剂、血管紧张素转换酶抑制剂/血管紧张素受体奈普赖素抑制剂、盐皮质激素受体拮抗剂和最新的钠-葡萄糖共转运蛋白2抑制剂)在随机对照试验(RCT)中显示出积极的结果。然而,最新的随机对照试验不适合进行比较,因为它们是在不同的时间进行的,背景疗法不同,而且入选的患者也没有相同的特征。因此,从这些审判中推断并提出适用于所有案件的共同框架的困难是显而易见的。尽管这四种制剂现在是HFrEF治疗的基本支柱,但引发和滴定的组合算法仍然存在争议。电解质紊乱在HFrEF患者中很常见,可归因于多种因素,如利尿剂的使用、肾损伤和神经激素激活。我们已经根据“现实世界”中的钠(Na+)和钾(K+)状态确定了几种HFrEF表型,并提出了一种算法,说明如何引入最合适的药物,并根据患者的电解质和充血的存在设置治疗。
{"title":"Medical Treatment in Heart Failure with Reduced Ejection Fraction: A Proposed Algorithm Based on the Patient's Electrolytes and Congestion Status.","authors":"Ioannis Paraskevaidis,&nbsp;Andrew Xanthopoulos,&nbsp;Nikolaos Karamichalakis,&nbsp;Filippos Triposkiadis,&nbsp;Elias Tsougos","doi":"10.3390/medsci11020038","DOIUrl":"10.3390/medsci11020038","url":null,"abstract":"<p><p>In heart failure (HF) with reduced ejection fraction (HFrEF), four classes of drugs (β-blockers, angiotensin-converting enzyme inhibitors/angiotensin receptor neprilysin inhibitors, mineralocorticoid receptor antagonists, and the most recent Sodium-Glucose Co-Transporters 2 Inhibitors) have demonstrated positive results in randomized controlled trials (RCTs). Nevertheless, the latest RCTs are not proper for comparison since they were carried out at various times with dissimilar background therapies and the patients enrolled did not have the same characteristics. The difficulty of extrapolating from these trials and proposing a common framework appropriate for all cases is thus obvious. Despite the fact that these four agents are now the fundamental pillars of HFrEF treatment, the built-up algorithm of initiation and titration is a matter of debate. Electrolyte disturbances are common in HFrEF patients and can be attributed to several factors, such as the use of diuretics, renal impairment, and neurohormonal activation. We have identified several HFrEF phenotypes according to their sodium (Na<sup>+</sup>) and potassium (K<sup>+</sup>) status in a \"real world\" setting and suggest an algorithm on how to introduce the most appropriate drug and set up therapy based on the patients' electrolytes and the existence of congestion.</p>","PeriodicalId":74152,"journal":{"name":"Medical sciences (Basel, Switzerland)","volume":"11 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302950/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10096472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gender Effects on Left Ventricular Responses and Survival in Patients with Severe Aortic Regurgitation: Results from a Cohort of 756 Patients with up to 22 Years of Follow-Up. 性别对严重主动脉瓣反流患者左心室反应和生存的影响:来自756例患者长达22年随访的结果。
Q1 Medicine Pub Date : 2023-05-23 DOI: 10.3390/medsci11020036
Padmini Varadarajan, Ramdas G Pai

Objectives: We sought to evaluate the effect of gender on biology, therapeutic decisions, and survival in patients with severe aortic regurgitation (AR).

Background: Gender affects adaptive response to the presence of valvular heart diseases and therapeutic decisions. The impact of these on survival in severe AR patients is not known.

Methods: This observational study was compiled from our echocardiographic database which was screened (1993-2007) for patients with severe AR. Detailed chart reviews were performed. Mortality data were obtained from the Social Security Death Index and analyzed as a function of gender.

Results: Of the 756 patients with severe AR, 308 (41%) were women. Over a follow-up of up to 22 years, there were 434 deaths. Women compared to men were older (64 ± 18 vs. 59 ± 17 years, p = 0.0002). Women also had smaller left ventricular (LV) end diastolic dimension (5.2 ± 1.1 vs. 6.0 ± 1.0 cm, p < 0.0001), higher EF (56% ± 17% vs. 52% ± 18%, p = 0.003), higher prevalence of diabetes mellitus (18% vs. 11%, p = 0.006), and higher prevalence of ≥2+ mitral regurgitation (52% vs. 40%, p = 0.0008) despite a smaller LV size. Women were also less likely to receive aortic valve replacement (AVR) (24% vs. 48%, p < 0.0001) compared to men and had a lower survival on univariate analysis (p = 0.001). However, after adjusting for group differences including AVR rates, gender was not an independent predictor of survival. However, the survival benefit associated with AVR was similar in both women and men.

Conclusions: This study strongly suggests that female gender is associated with different biological responses to AR compared to men. There is also a lower AVR rate in women, but women derive similar survival benefit as men with AVR. Gender does not seem to affect survival in an independent fashion in patients with severe AR after adjusting for group differences and AVR rates.

目的:我们试图评估性别对严重主动脉反流(AR)患者的生物学、治疗决策和生存的影响。背景:性别影响对瓣膜性心脏病的适应性反应和治疗决策。这些对严重AR患者生存的影响尚不清楚。方法:本观察性研究从我们筛选的严重AR患者的超声心动图数据库(1993-2007)中编译。进行详细的图表回顾。死亡率数据来自社会保障死亡指数,并作为性别的函数进行分析。结果:756例严重AR患者中,308例(41%)为女性。在长达22年的随访中,有434人死亡。女性比男性年龄大(64±18岁比59±17岁,p = 0.0002)。女性左室舒张末期尺寸较小(5.2±1.1 vs. 6.0±1.0 cm, p < 0.0001), EF较高(56%±17% vs. 52%±18%,p = 0.003),糖尿病患病率较高(18% vs. 11%, p = 0.006),尽管左室尺寸较小,但二尖瓣≥2+反流发生率较高(52% vs. 40%, p = 0.0008)。单因素分析显示,与男性相比,女性接受主动脉瓣置换术(AVR)的可能性更低(24%对48%,p < 0.0001),生存率也更低(p = 0.001)。然而,在调整了包括AVR率在内的组间差异后,性别并不是生存率的独立预测因子。然而,与AVR相关的生存获益在女性和男性中是相似的。结论:本研究强烈表明,与男性相比,女性对AR的生物学反应不同。女性的AVR率也较低,但女性获得的生存益处与男性相似。在调整组差异和AVR率后,性别似乎不会独立影响严重AR患者的生存。
{"title":"Gender Effects on Left Ventricular Responses and Survival in Patients with Severe Aortic Regurgitation: Results from a Cohort of 756 Patients with up to 22 Years of Follow-Up.","authors":"Padmini Varadarajan,&nbsp;Ramdas G Pai","doi":"10.3390/medsci11020036","DOIUrl":"https://doi.org/10.3390/medsci11020036","url":null,"abstract":"<p><strong>Objectives: </strong>We sought to evaluate the effect of gender on biology, therapeutic decisions, and survival in patients with severe aortic regurgitation (AR).</p><p><strong>Background: </strong>Gender affects adaptive response to the presence of valvular heart diseases and therapeutic decisions. The impact of these on survival in severe AR patients is not known.</p><p><strong>Methods: </strong>This observational study was compiled from our echocardiographic database which was screened (1993-2007) for patients with severe AR. Detailed chart reviews were performed. Mortality data were obtained from the Social Security Death Index and analyzed as a function of gender.</p><p><strong>Results: </strong>Of the 756 patients with severe AR, 308 (41%) were women. Over a follow-up of up to 22 years, there were 434 deaths. Women compared to men were older (64 ± 18 vs. 59 ± 17 years, <i>p</i> = 0.0002). Women also had smaller left ventricular (LV) end diastolic dimension (5.2 ± 1.1 vs. 6.0 ± 1.0 cm, <i>p</i> < 0.0001), higher EF (56% ± 17% vs. 52% ± 18%, <i>p</i> = 0.003), higher prevalence of diabetes mellitus (18% vs. 11%, <i>p</i> = 0.006), and higher prevalence of ≥2+ mitral regurgitation (52% vs. 40%, <i>p</i> = 0.0008) despite a smaller LV size. Women were also less likely to receive aortic valve replacement (AVR) (24% vs. 48%, <i>p</i> < 0.0001) compared to men and had a lower survival on univariate analysis (<i>p</i> = 0.001). However, after adjusting for group differences including AVR rates, gender was not an independent predictor of survival. However, the survival benefit associated with AVR was similar in both women and men.</p><p><strong>Conclusions: </strong>This study strongly suggests that female gender is associated with different biological responses to AR compared to men. There is also a lower AVR rate in women, but women derive similar survival benefit as men with AVR. Gender does not seem to affect survival in an independent fashion in patients with severe AR after adjusting for group differences and AVR rates.</p>","PeriodicalId":74152,"journal":{"name":"Medical sciences (Basel, Switzerland)","volume":"11 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303455/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10096469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient Dietary Supplements Use: Do Results from Natural Language Processing of Clinical Notes Agree with Survey Data? 患者膳食补充剂的使用:临床记录的自然语言处理结果与调查数据一致吗?
Q1 Medicine Pub Date : 2023-05-23 DOI: 10.3390/medsci11020037
Douglas Redd, Terri Elizabeth Workman, Yijun Shao, Yan Cheng, Senait Tekle, Jennifer H Garvin, Cynthia A Brandt, Qing Zeng-Treitler

There is widespread use of dietary supplements, some prescribed but many taken without a physician's guidance. There are many potential interactions between supplements and both over-the-counter and prescription medications in ways that are unknown to patients. Structured medical records do not adequately document supplement use; however, unstructured clinical notes often contain extra information on supplements. We studied a group of 377 patients from three healthcare facilities and developed a natural language processing (NLP) tool to detect supplement use. Using surveys of these patients, we investigated the correlation between self-reported supplement use and NLP extractions from the clinical notes. Our model achieved an F1 score of 0.914 for detecting all supplements. Individual supplement detection had a variable correlation with survey responses, ranging from an F1 of 0.83 for calcium to an F1 of 0.39 for folic acid. Our study demonstrated good NLP performance while also finding that self-reported supplement use is not always consistent with the documented use in clinical records.

膳食补充剂的使用很广泛,有些是处方药,但很多是在没有医生指导的情况下服用的。补充剂与非处方药和处方药之间有许多潜在的相互作用,而这些作用是患者所不知道的。结构化的医疗记录没有充分记录补充剂的使用;然而,非结构化的临床记录通常包含有关补充剂的额外信息。我们研究了来自三家医疗机构的377名患者,并开发了一种自然语言处理(NLP)工具来检测补充剂的使用。通过对这些患者的调查,我们调查了自我报告的补充剂使用与临床记录中NLP提取之间的相关性。我们的模型检测所有补充剂的F1得分为0.914。个别补充剂检测与调查结果有可变的相关性,从钙的F1为0.83到叶酸的F1为0.39不等。我们的研究显示了良好的NLP表现,同时也发现自我报告的补充剂使用情况并不总是与临床记录中的记录一致。
{"title":"Patient Dietary Supplements Use: Do Results from Natural Language Processing of Clinical Notes Agree with Survey Data?","authors":"Douglas Redd,&nbsp;Terri Elizabeth Workman,&nbsp;Yijun Shao,&nbsp;Yan Cheng,&nbsp;Senait Tekle,&nbsp;Jennifer H Garvin,&nbsp;Cynthia A Brandt,&nbsp;Qing Zeng-Treitler","doi":"10.3390/medsci11020037","DOIUrl":"https://doi.org/10.3390/medsci11020037","url":null,"abstract":"<p><p>There is widespread use of dietary supplements, some prescribed but many taken without a physician's guidance. There are many potential interactions between supplements and both over-the-counter and prescription medications in ways that are unknown to patients. Structured medical records do not adequately document supplement use; however, unstructured clinical notes often contain extra information on supplements. We studied a group of 377 patients from three healthcare facilities and developed a natural language processing (NLP) tool to detect supplement use. Using surveys of these patients, we investigated the correlation between self-reported supplement use and NLP extractions from the clinical notes. Our model achieved an F1 score of 0.914 for detecting all supplements. Individual supplement detection had a variable correlation with survey responses, ranging from an F1 of 0.83 for calcium to an F1 of 0.39 for folic acid. Our study demonstrated good NLP performance while also finding that self-reported supplement use is not always consistent with the documented use in clinical records.</p>","PeriodicalId":74152,"journal":{"name":"Medical sciences (Basel, Switzerland)","volume":"11 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304046/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10096466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metaplastic Carcinoma of the Breast: Case Series of a Single Institute and Review of the Literature. 乳腺化生癌:单一研究所病例系列及文献综述。
Q1 Medicine Pub Date : 2023-05-19 DOI: 10.3390/medsci11020035
Alkistis Papatheodoridi, Eleni Papamattheou, Spyridon Marinopoulos, Ioannis Ntanasis-Stathopoulos, Constantine Dimitrakakis, Aris Giannos, Maria Kaparelou, Michalis Liontos, Meletios-Athanasios Dimopoulos, Flora Zagouri

Metaplastic carcinoma of the breast (MpBC) is a very rare and aggressive type of breast cancer. Data focusing on MpBC are limited. The aim of this study was to describe the clinicopathological features of MpBC and evaluate the prognosis of patients with MpBC. Eligible articles about MpBC were identified by searching CASES SERIES gov and the MEDLINE bibliographic database for the period of 1 January 2010 to 1 June 2021 with the keywords metaplastic breast cancer, mammary gland cancer, neoplasm, tumor, and metaplastic carcinoma. In this study, we also report 46 cases of MpBC stemming from our hospital. Survival rates, clinical behavior, and pathological characteristics were analyzed. Data from 205 patients were included for analysis. The mean age at diagnosis was 55 (14.7) years. The TNM stage at diagnosis was mostly stage II (58.5%) and most tumors were triple negative. The median overall survival was 66 (12-118) months, and the median disease-free survival was 56.8 (11-102) months. Multivariate Cox regression analysis revealed that surgical treatment was associated with decreased risk of death (hazard ratio 0.11, 95% confidence interval 0.02-0.54, p = 0.01) while advanced TNM stage was associated with increased risk of death (hazard ratio 1.5, 95% confidence interval 1.04-2.28, p = 0.03). Our results revealed that surgical treatment and TNM stage were the only independent risk factors related to patients' overall survival.

乳腺化生癌(MpBC)是一种非常罕见的侵袭性乳腺癌。关注MpBC的数据有限。本研究的目的是描述MpBC的临床病理特征,并评估MpBC患者的预后。通过检索2010年1月1日至2021年6月1日期间的CASES SERIES gov和MEDLINE书目数据库,检索关键词为化生性乳腺癌、乳腺癌、肿瘤、肿瘤和化生性癌,确定符合条件的关于MpBC的文章。在本研究中,我们也报告了46例来自本院的MpBC病例。分析两组患者的生存率、临床行为及病理特征。来自205名患者的数据被纳入分析。平均诊断年龄为55岁(14.7岁)。诊断时TNM分期多为II期(58.5%),多数肿瘤为三阴性。中位总生存期为66(12-118)个月,中位无病生存期为56.8(11-102)个月。多因素Cox回归分析显示,手术治疗与死亡风险降低相关(风险比0.11,95%可信区间0.02 ~ 0.54,p = 0.01), TNM晚期与死亡风险增加相关(风险比1.5,95%可信区间1.04 ~ 2.28,p = 0.03)。我们的研究结果显示,手术治疗和TNM分期是与患者总生存相关的唯一独立危险因素。
{"title":"Metaplastic Carcinoma of the Breast: Case Series of a Single Institute and Review of the Literature.","authors":"Alkistis Papatheodoridi,&nbsp;Eleni Papamattheou,&nbsp;Spyridon Marinopoulos,&nbsp;Ioannis Ntanasis-Stathopoulos,&nbsp;Constantine Dimitrakakis,&nbsp;Aris Giannos,&nbsp;Maria Kaparelou,&nbsp;Michalis Liontos,&nbsp;Meletios-Athanasios Dimopoulos,&nbsp;Flora Zagouri","doi":"10.3390/medsci11020035","DOIUrl":"https://doi.org/10.3390/medsci11020035","url":null,"abstract":"<p><p>Metaplastic carcinoma of the breast (MpBC) is a very rare and aggressive type of breast cancer. Data focusing on MpBC are limited. The aim of this study was to describe the clinicopathological features of MpBC and evaluate the prognosis of patients with MpBC. Eligible articles about MpBC were identified by searching CASES SERIES gov and the MEDLINE bibliographic database for the period of 1 January 2010 to 1 June 2021 with the keywords metaplastic breast cancer, mammary gland cancer, neoplasm, tumor, and metaplastic carcinoma. In this study, we also report 46 cases of MpBC stemming from our hospital. Survival rates, clinical behavior, and pathological characteristics were analyzed. Data from 205 patients were included for analysis. The mean age at diagnosis was 55 (14.7) years. The TNM stage at diagnosis was mostly stage II (58.5%) and most tumors were triple negative. The median overall survival was 66 (12-118) months, and the median disease-free survival was 56.8 (11-102) months. Multivariate Cox regression analysis revealed that surgical treatment was associated with decreased risk of death (hazard ratio 0.11, 95% confidence interval 0.02-0.54, <i>p</i> = 0.01) while advanced TNM stage was associated with increased risk of death (hazard ratio 1.5, 95% confidence interval 1.04-2.28, <i>p</i> = 0.03). Our results revealed that surgical treatment and TNM stage were the only independent risk factors related to patients' overall survival.</p>","PeriodicalId":74152,"journal":{"name":"Medical sciences (Basel, Switzerland)","volume":"11 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204473/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9516156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Cervical Artery Dissection and Patent Foramen Ovale in Juvenile Stroke: Causality or Casuality? A Familiar Case Report. 颈动脉夹层和卵圆孔未闭在青少年中风中的作用:因果关系还是因果关系?一个熟悉的案例报告。
Q1 Medicine Pub Date : 2023-05-14 DOI: 10.3390/medsci11020034
Francesca Antonia Arcadi, Rosa Morabito, Silvia Marino, Caterina Formica, Rocco Salvatore Calabrò

Cervical artery dissection (CAD) and Patent Foramen Ovale (PFO) are important causes of stroke in young patients. Although PFO is considered an independent risk factor for cerebral infarction in young adults with cryptogenic stroke, other concomitant causes may be necessary to cause brain injury. PFO could be a predisposing factor of stroke through several mechanisms including paradoxical embolism from a venous source, thrombus formation in atrial septum, or atrial arrhythmias causing cerebral thromboembolism. The pathophysiology of CAD is poorly understood and includes both constitutional and environmental factors. A causal association is often difficult to establish, as other predisposing factors may also play a role in CAD etiopathogenesis. We present a family with ischemic stroke (a father and his three daughters), in which the two different stroke causes are present. We hypothesized that a paradoxical embolism caused by PFO, associated with arterial wall disease, in the presence of a procoagulant state, could produce arterial dissection and then stroke.

颈动脉夹层(CAD)和卵圆孔未闭(PFO)是年轻患者发生脑卒中的重要原因。虽然PFO被认为是年轻成人隐源性脑卒中脑梗死的独立危险因素,但其他伴随原因可能是导致脑损伤的必要因素。PFO可能通过几种机制成为中风的易感因素,包括静脉源性栓塞、房间隔血栓形成或心房心律失常引起脑血栓栓塞。CAD的病理生理学尚不清楚,包括体质和环境因素。因果关系往往难以确定,因为其他易感因素也可能在CAD发病中起作用。我们提出一个家庭缺血性中风(父亲和他的三个女儿),其中两种不同的中风原因是目前。我们假设,在促凝状态下,由PFO引起的与动脉壁疾病相关的矛盾栓塞可能导致动脉夹层,然后中风。
{"title":"Cervical Artery Dissection and Patent Foramen Ovale in Juvenile Stroke: Causality or Casuality? A Familiar Case Report.","authors":"Francesca Antonia Arcadi,&nbsp;Rosa Morabito,&nbsp;Silvia Marino,&nbsp;Caterina Formica,&nbsp;Rocco Salvatore Calabrò","doi":"10.3390/medsci11020034","DOIUrl":"https://doi.org/10.3390/medsci11020034","url":null,"abstract":"<p><p>Cervical artery dissection (CAD) and Patent Foramen Ovale (PFO) are important causes of stroke in young patients. Although PFO is considered an independent risk factor for cerebral infarction in young adults with cryptogenic stroke, other concomitant causes may be necessary to cause brain injury. PFO could be a predisposing factor of stroke through several mechanisms including paradoxical embolism from a venous source, thrombus formation in atrial septum, or atrial arrhythmias causing cerebral thromboembolism. The pathophysiology of CAD is poorly understood and includes both constitutional and environmental factors. A causal association is often difficult to establish, as other predisposing factors may also play a role in CAD etiopathogenesis. We present a family with ischemic stroke (a father and his three daughters), in which the two different stroke causes are present. We hypothesized that a paradoxical embolism caused by PFO, associated with arterial wall disease, in the presence of a procoagulant state, could produce arterial dissection and then stroke.</p>","PeriodicalId":74152,"journal":{"name":"Medical sciences (Basel, Switzerland)","volume":"11 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204567/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9516157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Medical sciences (Basel, Switzerland)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1